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Mario Cortina-Borja, PhD,† Alison Brown, PhD,‡ Valerie Delpech, FPHM,‡ and Pat A. Tookey, PhD†Background: Little is known about retention in human immunodeficiency
virus (HIV) care in HIV-positive women after pregnancy in the United
Kingdom. We explored the association between loss to follow-up (LTFU)
in the year after pregnancy, maternal place of birth and duration of UK resi-
dence, in HIV-positive women in England, Wales, and Northern Ireland.
Methods:We analyzed combined data from 2 national data sets: the Na-
tional Study of HIV in Pregnancy and Childhood; and the Survey of Prev-
alent HIV Infections Diagnosed, including pregnancies in 2000 to 2009 in
womenwith diagnosed HIV. Logistic regressionmodels were fittedwith ro-
bust standard errors to estimate adjusted odds ratios (AOR).
Results: Overall, 902 of 7211 (12.5%) women did not access HIV care in
the year after pregnancy. Factors associated with LTFU included younger
age, last CD4 in pregnancy of 350 cells/μL or greater and detectable HIV
viral load at the end of pregnancy (all P < 0.001). Onmultivariable analysis,
LTFUwasmore likely in sub-SaharanAfrica-born (SSA-born) women than
white UK-born women (AOR, 2.17; 95% confidence interval, 1.50–3.14;
P < 0.001). The SSA-born women who had migrated to the UK during
pregnancy were 3 times more likely than white UK-born women to be lost
to follow-up (AOR, 3.19; 95% confidence interval, 1.94–3.23; P < 0.001).
Conclusions: One in 8HIV-positivewomen in England,Wales, andNorthern
Ireland did not return for HIV care in the year after pregnancy, with SSA-
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Between 1200 and 1400 pregnancies are reported in the UnitedKingdom and Ireland each year amongwomenwith diagnosed
human immunodeficiency virus (HIV) infection,1 most of whom
have migrated from sub-Saharan Africa.2 The UK and Ireland
have a successful program for the prevention of vertical trans-
mission of HIV, with a vertical transmission rate of approxi-
mately 0.5%.3 Women living with HIV receive antenatal care
free of charge, with care usually provided by a multidisciplin-
ary team including specialist staff from HIV medicine, obstet-
rics and pediatrics, and the voluntary sector.
Sustained engagement with HIV services is important after
pregnancy, safeguarding women's health, as well as potentially re-
ducing the risk of unplanned pregnancy and onward transmission
of HIV through the provision of contraception and antiretroviral
therapy (ART). Discontinuation of ART postpartum has been as-
sociated with adverse outcomes, such as detectable viral load at
delivery in subsequent pregnancies,4 and increased morbidity
and mortality.5 However, early engagement with HIV servicesfrom J.E., P.T., and M.C.B., and drafted the first version of this
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Tariq et al.postpartum has been shown to be associated with virologic sup-
pression in the longer term.6
Current UK standards of care for people living with HIV
state that >95% of patients should access services at least annually.7
Studies conducted in the UK looking at loss to follow-up (LTFU) at
1 year among HIV-positive adults have reported rates ranging from
2.5% to 20%, with female sex, younger age, recent diagnosis of
HIV, and not being on ARTassociated with an increased risk of dis-
engagement from care.8–10 A consistent finding across these studies
is the association between black African ethnicity and LTFU.8–10
Women may face particular challenges in engaging with
HIV services after pregnancy. However, few studies have explored
LTFU after pregnancy in women living with HIV, and most of
those have been conducted in low-income settings, revealing high
rates of attrition.11–13 Data on retention in HIV care after preg-
nancy in high-resource settings are more limited. Studies in the
United States have reported attrition rates of between 40% and
60% 1 year after delivery,6,14 whereas a recent analysis of data
from the Swiss HIV Cohort Study has revealed a LTFU rate of
12% 1 year postpartum.15 To the best of our knowledge, there
are no published data on LTFU after pregnancy in women liv-
ing with HIV in the United Kingdom.
We present one of the largest studies to date in a high-
income setting to explore retention in HIV care in women after
pregnancy. Specifically, we aim to examine the association be-
tween LTFU from HIV care in the calendar year after preg-
nancy and: (i) maternal ethnicity/region of birth and (ii)
maternal duration of residence in the United Kingdom, hypoth-
esizing that migrants, especially those living in the United
Kingdom for a shorter time, may encounter particular chal-
lenges in accessing ongoing HIV care.MATERIALS AND METHODS
We present an analysis of data from a matched dataset cre-
ated from two national HIV datasets in the United Kingdom: the
National Study of HIV in Pregnancy and Childhood (NSHPC)
and the Survey of Prevalent Infections Diagnosed (SOPHID).Data Sources
TheNational StudyofHIV in Pregnancy andChildhood
The NSHPC, coordinated at the University College London
Institute of Child Health, is a comprehensive population-based ac-
tive surveillance study of obstetric and pediatric HIV in the United
Kingdom and Ireland. Pregnancies in HIV-positive women di-
agnosed by the time of delivery, and infants born to HIV-
positive women, are reported through 2 active parallel schemes
managed in collaboration with the Royal College of Obstetri-
cians and Gynaecologists and the British Paediatric Surveil-
lance Unit; full methods are described elsewhere.16
The Survey of Prevalent HIV Infections Diagnosed
SOPHID is a cross-sectional survey of all individuals aged
15 and abovewith diagnosed HIV infection who attend for National
Health Service (NHS) HIV care in England, Wales, and Northern
Ireland (EW&NI)within a calendar year; again, full methods are de-
scribed elsewhere.17 Providers of HIV care submit demographic
and clinical data on all individuals who have attended their centre
for HIV-related care to Public Health England annually (twice a year
in London). Individual data are linked to data from previous years to
form a national cohort of persons attending for HIV care.284 Sexu
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To ascertain whether a woman returned for HIV care any-
where in EW&NI in the calendar year after the end of pregnancy,
we created a combined dataset using NSHPC and SOPHID
data. Women known by the NSHPC to be pregnant between
2000 and 2009 were matched to the SOPHID data set by year
of pregnancy. A hierarchical matching strategy was imple-
mented, using limited identifiers, such as sex, date of birth
and residential information. Deaths in women previously re-
ported to the NSHPC were identified through linking of death re-
cords held at Public Health England and collated through the
Office for National Statistics.
Eligibility
The analysis was restricted to women with pregnancies
reported to the NSHPC with a year of delivery (or estimated
date of delivery [EDD] if the outcome was not a live or still
birth) between January 2000 and December 2009. During this
time, management of HIV in pregnancy in the United Kingdom
remained broadly consistent. We only included pregnancies in
sub-Saharan Africa-born (SSA-born) and white UK-born women
due to small numbers in other ethnic groups. Pregnancies or atten-
dances reported in Ireland and Scotland were excluded from this
analysis. The SOPHID does not have data on attendance for
HIV care in Ireland. At the time of analysis, Scottish reports to
SOPHID before 2008 were not linked over time, and it was there-
fore difficult to establish links between records on the same patient
over time reliably.
Variables
Maternal ethnicity/region of birth was based on recorded
ethnicity and country of birth on NSHPC notification forms and
categorized as “sub-Saharan Africa-born” (of black African eth-
nicity and born in sub-Saharan Africa) and “white UK-born” (of
white ethnicity and born in the United Kingdom). Maternal dura-
tion of residence in the UK for SSA-born women was based on the
length of time in years between reported date of entry to the United
Kingdom and estimated date of conception for the reported preg-
nancy. It was categorized as “>10 years”, “5–10 years,” and
“<5 years (before conception).” We hypothesized a priori that
women who had migrated to the United Kingdom after concep-
tion of the reported pregnancy may be a particularly vulnerable
group in terms of access to healthcare and grouped these
women separately. Loss to follow-up was defined as no docu-
mented attendance for HIV care at an NHS clinic in EW&NI
during the calendar year after the confirmed or estimated end
of pregnancy.
Statistical Analysis
Data were analyzed using Stata 11.2 (Stata Corporation,
College Station, TX). A χ2 test was performed to compare HIV
follow-up after pregnancy in women by ethnicity and duration
of residence in the United Kingdom. Those who attended for
HIV follow-up in the year after pregnancy were compared with
those who did not using univariable and multivariable logistic
regression models to estimate odds ratios (ORs) and adjusted
ORs (AORs), with 95% confidence intervals (95% CI). Year
of delivery (or EDD) was included in all final multivariable models
as an a priori confounder. Other variables were included if their in-
clusion significantly improved model fit. This was assessed using
likelihood ratio tests, with a significance level of P less than 0.05.
Sequential pregnancies in the same woman were included in
the analysis as independent observations with robust standard
errors to account for clustering.18ally Transmitted Diseases • Volume 43, Number 5, May 2016
sociation. Unauthorized reproduction of this article is prohibited.
TABLE 1. Demographic and Clinical Characteristics of Women With Pregnancies Reported to the NHSPC in 2000–2009 by Maternal
Follow-Up in the Calendar Year After Pregnancy
Not LTFU by 1 Year, n (Row %) (n = 6309) LTFU by 1 y, n (Row %) (n = 902) P*
Ethnicity/region of birth
White UK-born 669 (92.2) 57 (7.9) <0.001
Sub-Saharan Africa-born 5640 (87.0) 845 (13.0)
Duration of residence in the UK, y†
>10 y (before conception) 446 (91.0) 44 (9.0) <0.001
5–10 y (before conception) 1197 (90.8) 122 (9.2)
<5 y (before conception) 1967 (87.0) 293 (13.0)
Since conception 240 (76.2) 75 (23.8)
Maternal age at delivery, y
<25 808 (83.3) 162 (16.7) <0.001
25–34 3853 (87.9) 530 (12.1)
≥35 1556 (91.2) 151 (8.9)
Year of EDD/delivery
2000–2003 1487 (86.2) 238 (13.8) 0.003
2004–2006 2188 (86.5) 341 (13.5)
2007–2009 2634 (89.1) 323 (10.9)
IDU
No 6271 (87.5) 900 (12.6) 0.150
Yes 38 (95.0) 2 (5.0)
Last CD4 count,‡ cells/μL
≥350 3339 (87.5) 478 (12.5) <0.001
200–249 1544 (90.6) 161 (9.4)
<200 639 (91.2) 62 (8.8)
Last HIV viral load,‡ copies/mL
<50 3632 (90.9) 366 (9.2) <0.001
≥50 1944 (84.6) 355 (15.4)
Time since HIV diagnosis, y
>5 1199 (93.4) 85 (6.6) <0.001
1–5 2100 (89.2) 254 (10.8)
<1 2510 (84.9) 446 (15.1)
Reporting region
London 3043 (89.3) 363 (10.7) 0.001
England (not London) 2564 (86.2) 410 (13.8)
Wales and Northern Ireland 90 (90.0) 10 (10.0)
Outcome of pregnancy
Live birth 5610 (87.9) 769 (12.1) 0.594
Still birth 65 (86.7) 10 (13.3)
Miscarriage/ectopic 333 (90.2) 36 (9.8)
Termination 209 (88.2) 28 (11.9)
Gestation at delivery,§ wk
≥37 4833 (87.9) 666 (12.1) 0.634
<37 811 (88.4) 106 (11.6)
*Obtained using χ2 test.
†Restricted to sub-Saharan Africa-born women.
‡ Last reported value in pregnancy.
§ Restricted to live and still births.
IDU indicates likely route of HIVacquisition was maternal injecting drug use.
Loss to Follow-up After PregnancyAs a sensitivity analysis, we coded all pregnancies that were
not matched as lost to follow-up and refitted all multivariable
models to explore the effects on estimates.RESULTS
There were 8150 eligible pregnancies occurring between
January 2000 and December 2009 and reported to the NSHPC
by March 2011. Among these, 7219 (88.6%) were in women
who had a matched record in the SOPHID database.
Eight women who were known to have died in either the
year of pregnancy, or the year after, were excluded from the
analysis. This analysis is therefore based on 7211 pregnancies
in 5390 women.Sexually Transmitted Diseases • Volume 43, Number 5, May 2016
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Demographic and clinical characteristics of the study
population are presented in Table 1. Nearly 90% of pregnancies
(6485/7211) were in SSA-born women; of whom two thirds had
data available on duration of residence in the United Kingdom
(4384/6485), with a median of 4.0 years (interquartile range
[IQR], 1.7–6.8 years). Just over 10% had lived in the UK for
10 or more years (490/4384), whereas 318 (7.2%) had arrived
in the United Kingdom during the reported pregnancy. Most
SSA-born women were born in Eastern (3919/6485, 60.4%)
or Western Africa (1415/6485, 21.8%).
Overall, after 12.5% of pregnancies reported to the NSHPC
women did not access HIV care in the year after (902/7211; 95%
CI: 11.7%, 13.3%). This proportion rose to 22.5% (1833/8142;
95% CI, 21.6–23.4%) when unmatched records were included285
sociation. Unauthorized reproduction of this article is prohibited.
Figure 1. Loss to follow-up in the calendar year following
pregnancy, 2000–2009.
Tariq et al.and coded as lost to follow-up. Therefore, the proportion of
pregnancies where women were lost to follow-up in the subse-
quent year was likely to be between 12.5% and 22.5%.
The percentage of LTFU varied over time rising from
9.0% in 2000 to a peak of 15.1% in 2003, falling to 11.1%
in 2009 (P < 0.05; Fig. 1). Of the 902 women who did notTABLE 2. Univariable and Multivariable Analysis of the Association Betw
Calendar Year After Pregnancy
Univariable Analyses
OR (95% CI)
Ethnicity/region of birth
White British UK-born 1.00
Sub-Saharan Africa-born 1.76 (1.34–2.33)
Maternal age at delivery, y
<25 1.00
25–34 0.69 (0.57–0.83)
≥35 0.48 (0.38–0.61)
Year of EDD/delivery
2000–2003 1.00
2004–2006 0.97 (0.81–1.16)
2007–2009 0.77 (0.64–0.92)
IDU
No 1.00
Yes 0.37 (0.09–1.52)
Last CD4 count,* cells/μL
≥350 1.00
200–249 0.73 (0.60–0.88)
<200 0.68 (0.51–0.89)
Last HIV viral load,* copies/mL
<50 1.00
≥50 1.81 (1.55–2.12)
Time since HIV diagnosis, y
>5 1.00
1–5 1.71 (1.32–2.20)
<1 2.51 (1.97–3.19)
Reporting region
London 1.00
England (not London) 1.34 (1.15–1.56)
Wales and Northern Ireland 0.93 (0.48–1.81)
Outcome of pregnancy
Live birth 1.00
Still birth 1.12 (0.57–2.19)
Miscarriage/ectopic 0.79 (0.55–1.12)
Termination 0.98 (0.65–1.46)
Gestation at delivery, wk
≥37 1.00
<37 0.95 (0.76–1.18)
*Last reported test in pregnancy. IDU, likely route of HIVacquisition was m
286 Sexu
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turned in the subsequent year. After excluding women who
died during the study period, a total of 460 women who had
been reported as pregnant to the NSHPC between 2000 and
2009 had not returned for follow-up by the end of 2010
(6.4%; 95% CI, 5.8–6.9%).
Univariable analyses revealed an association between
LTFU and younger maternal age at delivery, earlier year of
EDD/delivery, higher maternal CD4 count at the end of preg-
nancy, detectable maternal viral load at the end of pregnancy,
more recent maternal HIV diagnosis and pregnancy being re-
ported in areas of England outside London (all P < 0.05;
Table 1). There was no association between LTFU and either
injecting drug use as the route of HIV acquisition or outcome
of pregnancy (P > 0.1).
A greater proportion of SSA-born women (13.0%; 845/
6485) were lost to follow-up compared with women white
UK-born women (7.9%; 57/726; P < 0.001). After adjusting
for maternal age, year, last CD4 count and viral load in preg-
nancy, time since HIV diagnosis and reporting area, SSA-
born women were twice as likely as white UK-born women to
be lost to follow-up in the year subsequent to their pregnancy
(AOR, 2.17; 95% CI, 1.50–3.14; P < 0.001; Table 2). This as-
sociation persisted but was attenuated on including womeneen Maternal Ethnicity/Region of Birth and Loss to Follow-Up in the
Multivariable Analysis, n = 5741
P AOR (95% CI) P
1.00
<0.001 2.17 (1.50–3.14) <0.001
<0.001 1.00
0.73 (0.58–0.92) 0.009
0.67 (0.50–0.91) 0.009
0.003 1.00
1.04 (0.82–1.31) 0.743
0.97 (0.76–1.24) 0.820
0.107
<0.001 1.00
0.69 (0.56–0.84) <0.001
0.50 (0.36–0.70) <0.001
<0.001 1.00 <0.001
1.78 (1.47–2.16)
1.00
<0.001 1.54 (1.13–2.09) 0.006
1.95 (1.43–2.67) <0.001
0.001 1.00
1.29 (0.36–0.70) 0.007
1.28 (0.59–2.74) 0.532
0.575
0.634
aternal injecting drug use.
ally Transmitted Diseases • Volume 43, Number 5, May 2016
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TABLE 3. Univariable and Multivariable Analysis of the Association Between Maternal Duration of Residence in the United Kingdom at
Conception (in Reported Pregnancy) and Loss to Follow-Up in the Calendar Year After Pregnancy (Restricted to Those With Data on Duration
of Residence in the United Kingdom)
Univariable Analyses Multivariable Analysis, n = 4043
OR (95% CI) P AOR (95% CI) P
Duration of residence in United Kingdom
White UK-born 1.00 <0.001 1.00
SSA-born >10 y (before conception) 1.16 (0.77–1.75) 2.27 (1.27–4.02) 0.005
SSA-born 5–10 y (before conception) 1.20 (0.86–1.66) 1.88 (1.21–2.94) 0.005
SSA-born < 5 y (before conception) 1.75 (1.30–2.35) 2.18 (1.47–3.22) <0.001
SSA-born since conception 3.67 (2.52–5.33) 3.19 (1.94–3.23) <0.001
Maternal age at delivery, y
<25 1.00 <0.001 1
25–34 0.74 (0.55–0.92) 0.72 (0.55–0.96) 0.024
≥35 0.55 (0.41–0.73) 0.72 (0.51–1.02) 0.064
Year of EDD/delivery
2000–2003 1.00 0.076 1.00
2004–2006 1.12 (0.84–1.61) 1.60 (1.03–2.51) 0.039
2007–2009 0.94 (0.68–1.30) 1.51 (0.95–2.40) 0.085
Last CD4 count,* cells/μL
≥350 1.00 <0.001 1.00
200–249 0.68 (0.54–0.85) 0.63 (0.50–0.81) <0.001
<200 0.59 (0.41–0.85) 0.40 (0.26–0.61) <0.001
Last HIV viral load,* copies/mL
<50 1.00 <0.001 1.00
≥50 1.75 (1.45–2.12) 1.79 (1.43–2.25) <0.001
Time since HIV diagnosis, y
>5 1.00 <0.001 1.00
1–5 1.74 (1.28–2.36) 1.50 (1.04–2.16) 0.030
<1 2.59 (1.94–3.45) 1.79 (1.22–2.63) 0.003
Reporting region
London 1.00 0.004 1.00
England (not London) 1.37 (1.14–1.64) 1.32 (1.05–1.66) 0.017
Wales and Northern Ireland 1.31 (0.64–2.66) 1.68 (0.73–3.89) 0.224
Outcome of pregnancy
Live birth 1.00 0.299
Still birth 0.70 (0.25–1.95)
Miscarriage/ectopic 0.75 (0.49–1.17)
Termination 0.79 (0.46–1.36)
Gestation at delivery, wk
≥37 1.00 0.080
<37 0.82 (0.65–1.03)
*Last reported test in pregnancy. IDU, likely route of HIVacquisition was maternal injecting drug use.
Loss to Follow-up After Pregnancywho had not been matched across the data sets (AOR, 1.65;
95% CI, 1.27–2.16; P < 0.001).Subgroup Analysis Among Women With Data on
Duration of Residence in the United Kingdom
This analysis included 726 white UK-born women, and
4384 SSA-born women who had available data on maternal du-
ration of residence in the United Kingdom. There was a differ-
ence in LTFU according to maternal duration of residence in the
UK. Among SSA-born women, a greater proportion of those
who had arrived in the United Kingdom during the reported
pregnancy (23.8%; 75/315), or had arrived less than 5 years be-
fore conception (13.0%; 293/2260), did not return for HIV care
in the year after pregnancy compared with women who had re-
sided in the United Kingdom for 5 or more years (9.2%; 166/
1809; P < 0.001; Table 1).
After adjusting for year, last CD4 count and viral load in
pregnancy, time since HIV diagnosis and reporting area, the odds
of not returning to care in the year after pregnancy were higher for
all SSA-born women (regardless of duration of residence in the
United Kingdom) compared with white UK-born women (allSexually Transmitted Diseases • Volume 43, Number 5, May 2016
Copyright © 2016 by the American Sexually Transmitted Diseases AsP < 0.01; Table 3). Women who had arrived in the United
Kingdom after conception were the most likely group to be lost
to follow-up (AOR, 3.19; 95% CI, 1.94–3.23; P < 0.001). When
unmatched women were included in the analysis and coded as lost
to follow-up, the odds of LTFU no longer reached statistical signif-
icance in SSA-born women who had lived in the United Kingdom
for more than 10 years (AOR, 1.34; 95% CI, 0.386–2.10;
P = 0.201) or between 5 and 10 years (AOR, 1.30; 95% CI,
0.94–1.81; P = 0.108). The odds of LTFU were attenuated but
remained statistically significant in both SSA-born women who
had migrated less than 5 years before their pregnancy (AOR,
1.56; 95% CI, 1.18–2.08; P = 0.002) and those who migrated dur-
ing pregnancy (AOR, 2.27; 95% CI, 1.56–3.29; P < 0.001).
DISCUSSION
In this analysis of 7211 pregnancies occurring in EW&NI
during 2000–2009 and reported to the United Kingdom and
Ireland's national surveillance programme, we found that 1 in 8
women with diagnosed HIV did not return for HIV care in the cal-
endar year after their pregnancy.
The proportion of women lost to follow-up after pregnancy
reported in this article appears to be consistent with data from a287
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Tariq et al.previous analysis of UK surveillance data looking at attendance
for HIV care in the general HIV-positive population in EW&NI,8
but is over twice as high as the rate reported in a recent national
audit of LTFU in HIV-positive adults.10 Of note, we have also
demonstrated a similar LTFU rate as that reported in a recent anal-
ysis of data on postnatal retention in care in the Swiss HIV Cohort
Study.15 Although the proportion of women we identified as lost
to follow-up after pregnancy is lower than those described in most
studies conducted outside the United Kingdom, it falls short of
current UK standards which state that more than 95% of HIV-
positive patients should access HIV services at least once a year.7
Furthermore, almost 50% of women who did not return for HIV
care after pregnancy had a detectable viral load at delivery and
were therefore potentially at risk of passing HIV onto any HIV-
negative sexual partners. Current UK guidelines recommend of-
fering patients ART regardless of CD4 count to protect their sexual
partners andmaintain their own health.19Women lost to follow-up
will not have benefited from the clinical and public health benefits
of this intervention.
Deaths may be underreported or underidentified through
linking to the Office for National Statistics; however, they are
likely to be few in number and not a major contributory factor to
estimates of LTFU. Nearly 90% of women in this analysis had mi-
grated from sub-Saharan Africa, and it is therefore reasonable to
assume that emigration may be an important explanatory factor.
A recent audit on retention in care in UK HIV services for adults
found that 1 in 4 HIV-positive patients not attending for care were
known to have left the United Kingdom.10 Data on emigration are
not available in either the NSPHC or SOPHID datasets, limiting
our interpretation.
However, difficulties in accessing care may also play an im-
portant role. Factors already known to be associated with disen-
gagement from care after pregnancy in non-UK settings include
care-giving responsibilities,20,21 suboptimal antenatal care ac-
cess,6,12 institutional barriers,13,21,22 maternal substance misuse,15
lack of financial resources,22 concerns about HIV disclosure and
stigma,12,22,23 and the lack of support especially from partners.21,23,24
Furthermore, women may be highly motivated to engage with care
during pregnancy in an effort to secure the health of their baby, but
may be less motivated about their own health after delivery.25
The overwhelming majority of HIV-positive pregnant
women reported during this period were migrants from sub-
Saharan Africa, and they were more likely than white UK-born
women not to attend for HIV care in the year after pregnancy. This
is in keeping with other studies that have examined the association
between Black African ethnicity and poorer retention in HIV care
in the United Kingdom.8–10 Furthermore, we observed poorer re-
tention in care among all SSA-born women regardless of duration
of residence in the United Kingdom, with those who had migrated
during pregnancy being 3 times as likely as white-UK born
women to be lost to follow-up. To the best of our knowledge, this
is the first study to specifically look at the association between
time since migration and retention in HIV care.
Although emigration may be an important explanation for
SSA-born women being more likely to be lost to follow-up after
pregnancy, it is reasonable to hypothesize that this group may also
encounter particular social and structural challenges in accessing
HIV services in the long term. Many African migrants living with
HIV in the United Kingdom have a high level of social need in-
cluding financial difficulty,26 social isolation27 and immigration
issues.28 Recently arrived migrants may be at particular risk of
LTFU due to a complex interplay between insecure immigration
status, poverty, and service-related barriers.29 It is worth noting
that between 2004 and 2012, undocumented migrants and those
whose asylum claims had failed were not entitled to free secondary288 Sexu
Copyright © 2016 by the American Sexually Transmitted Diseases Ascare within the NHS (including antiretroviral therapy outside
of pregnancy).30
There are limitations in matching records across 2 large na-
tional epidemiological datasets which do not share a unique iden-
tifier. Incomplete reporting and coding errors in variables would
result in a nonmatch and an overestimation of LTFU. Furthermore,
inconsistencies in date of birth or residential postcode (which oc-
curs in the context of undocumented migration and highly mobile
populations, both groups who are likely to be included in the
datasets) would also prevent matching. Although we cannot ex-
clude bias being introduced by non-matches, we are reassured
by the lack of evidence of an association between unmatched
records and maternal ethnicity/region of birth (P > 0.1). Some
women whowere not matched across the datasets may have dis-
engaged from care after pregnancy leading to possible underes-
timation of LTFU. Sensitivity analyses showed little effect on
ORs in the analysis of ethnicity/region of birth, but did affect
estimates in the analysis of duration of residence. However,
the associations between LTFU and being resident in the United
Kingdom for less than 5 years, although attenuated, remained sig-
nificant. It is important to acknowledge that we lack information
on potentially important confounders such as socioeconomic and
immigration status. We also recognize that the category SSA-
born elides important heterogeneity; however, we hypothesized that
there may be shared experiences of migration and use this as a heu-
ristic device. Finally, these data only reflect attendances for HIV
care by the mother and do not capture return for infant care only.
We are therefore unable to comment on return for infant testing.
In conclusion, this is one of the largest analyses to date of
longitudinal observational data internationally to examine reten-
tion in HIV care after pregnancy, and one of very few to be con-
ducted in a high-income setting. It is likely to be representative
of experience in EW&NI as the NSHPC and SOPHID both have
national coverage and high response rates.8 It is reassuring that
nearly 90% of women in the United Kingdom with diagnosed
HIV infection accessed HIV care in the calendar year after
pregnancy. However, 1 in 8 HIV-positive women in EW&NI
did not return for HIV care in the year after pregnancy, with re-
cently diagnosed women and SSA-born women, especially
those who migrated to the United Kingdom during pregnancy,
at increased risk. Although emigration is a possible explanatory
factor, withdrawal from care may play an important role. It is
important for healthcare providers to be aware of the risk of
LTFU after pregnancy, especially among women who have
been diagnosed recently, those with a detectable viral load at
delivery (who may have encountered challenges in adherence
and engagement in care), and those from migrant African com-
munities, and to identify culturally sensitive ways of supporting
women in accessing long-term HIV care without interruption.REFERENCES
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